Youngevity International Inc. v. Innov8tive Nutrition, Inc.

District Court, S.D. California·Decided March 22, 2023·No. 3:22-cv-00721·Unknown

Opinion

YOUNGEVITY INT’L, INC., Case No.: 22cv721-LL-WVG

Plaintiff, ORDER GRANTING v. MOTION TO DISMISS

INNOV8TIVE NUTRITION, INC., et al, [ECF No. 8] Defendants. This matter is before the Court on the Motion of Defendants Innov8tive Nutrition, Inc. (“Innov8tive”), LaCore Nutraceuticals, Inc. (“LCN”), LaCore Enterprises, LLC (“LCE”), and LaCore Labs, Inc. (“LCL”), to dismiss the complaint of Plaintiff Youngevity International, Inc. (“Youngevity”) for lack of jurisdiction pursuant to Federal Rule of Civil Procedure 12(b)(2).1 ECF No. 8. The Court finds this matter suitable for determination on

1 Plaintiff does not present arguments supporting the exercise of personal jurisdiction over Defendants LCN or LCL and does not object to their dismissal without prejudice on 12(b)(2). See ECF No. 9 at 7. Accordingly, LaCore Nutraceticals, Inc. and LaCore Labs, Inc. are DISMISSED WITHOUT PREJUDICE for lack of personal jurisdiction. The Court’s Order therefore addresses arguments pertaining to the remaining defendants, the papers and without oral argument pursuant to Federal Rule of Civil Procedure 78(b) and Civil Local Rule 7.1.d.1. Upon review of the parties’ submissions and the applicable law, the Court GRANTS the Motion to Dismiss for the reasons stated below. Plaintiff Youngevity brought this action on May 19, 2022, asserting claims under the Lanham Act, 15 U.S.C. § 1125, for false or misleading advertising, and for false advertising and unlawful conduct under section 17200 of the California Business & Professions Code (“UCL”). ECF No. 1 ¶¶ 46-180. Defendants filed the instant Motion to Dismiss Plaintiff’s complaint in its entirety for lack of personal jurisdiction under Rule 12(b)(2) of the Federal Rules of Civil Procedure. ECF No. 8. The Motion to Dismiss has been fully briefed. See ECF Nos. 8-10. Plaintiff Youngevity is a network marketing company that operates under the laws of Delaware and has its principal place of business in Chula Vista, California. ECF No. 1 ¶ 2. Plaintiff develops and distributes dietary supplement products via “independent, direct- sellers known as ‘distributors’” who market its products through “websites, media, trade shows, lectures, community events, local shops, and home meetings” and sell its products through “peer-to-peer relationships, e-commerce, and social media marketing.” Id. ¶¶ 3-5. Plaintiff specializes in selling “high-quality dietary supplement products which consumers can ingest in liquid, powder, or capsule form.” Id. ¶ 4. Defendants Innov8tive, along with LCE, LCN, and LCL, are businesses based in the state of Texas. ECF No. 1. ¶¶ 7-12. Innov8tive’s principal place of business is in Melissa, Texas. Id. ¶ 7. Plaintiff alleges that LCE purports to be a sales development and investment agency, that LCN purports to be a contract manufacturer of dietary supplements, sports nutrition, and personal care products, that LCL purports to be a full-service independent testing laboratory, that LCE is the parent company of both LCN and LCL (collectively, the “LaCore Entities”), and that Innov8tive is a network marketing company. Id. ¶¶ 7-12, 14. In particular, Plaintiff alleges that the LaCore Entities manufacture, package and distribute certain patch products marketed by Innov8tive that are “purported to provide consumers with vitamins, minerals, and/or nutrients through a patch placed on the skin” based on the premise that “consumers would absorb transdermally the dietary ingredients directly through the skin.” Id. ¶¶ 21-22, 31. Youngevity and Innov8tive are “direct competitors in that they both sell products advertised to contain vitamins and nutrients to consumers through independent distributors” and “therefore compete for the same target consumers[.]” Id. ¶ 33. Plaintiff alleges two misrepresentations in Innov8tive’s advertisements. First, it alleges that Innov8tive’s claims that its patch products facilitate absorption of dietary ingredients through the topical patches applied to the skin are false. ECF No. 1 ¶¶ 51-53. Second, Plaintiff alleges that the claims made by Innov8tive’s product labels, which purport to show the amounts of vitamins, minerals, nutrients, and percent daily values of each ingredient, are false. Id. ¶¶ 56-57. Plaintiff contends that, as a result of Innov8tive’s misrepresentations and because Innov8tive markets its products directly to Youngevity distributors and customers, Plaintiff has lost distributors and customers to Innov8tive. Id. ¶¶ 33, 48, 49. Plaintiff further alleges that Defendants’ practices deceive consumers [id. ¶ 138], have caused economic injury to Plaintiff [id. ¶ 139], and violate California law [id. ¶ 154]. Plaintiff seeks injunctive relief enjoining Defendants from making the alleged false claims, selling the patch products or any other topical products intended for transdermal administration of dietary supplements; exemplary or punitive damages; disgorgement of Defendants’ profits earned as a result of the sale of the patch products; and costs and attorney fees related to this suit. Id. ¶¶ A-J. Under Federal Rule of Civil Procedure 12(b)(2), a party may move to dismiss a complaint for lack of personal jurisdiction. Fed. R. Civ. P. 12(b)(2). “Where a defendant moves to dismiss a complaint for lack of personal jurisdiction, the plaintiff bears the burden of demonstrating that jurisdiction is appropriate.” Schwarzenegger v. Fred Martin Motor Co., 374 F.3d 797, 800 (9th Cir. 2004) (citing Sher v. Johnson, 911 F.2d 1357, 1361 (9th Cir. 1990)). If the Rule 12(b)(2) motion “is based on written materials rather than an evidentiary hearing, the plaintiff need only make a prima facie showing of jurisdictional facts to withstand the motion to dismiss.” Mavrix Photo, Inc. v. Brand Techs., Inc., 647 F.3d 1218, 1223 (9th Cir. 2011) (citing Brayton Purcell LLP v. Recordon & Recordon, 606 F.3d 1124, 1127 (9th Cir. 2010)). While uncontroverted allegations in the complaint are taken as true, the court “cannot ‘assume the truth of allegations which are contradicted by affidavit.”’ LNS Enters. LLC v. Cont’l Motors, Inc., 22 F.4th 852, 858 (9th Cir. 2022) (quoting Data Disc., Inc. v. Sys. Tech. Assocs., Inc., 557 F.2d 1280, 1284 (9th Cir. 1977)). Where both sides submit affidavits, conflicts over the statements contained in affidavits are resolved in the plaintiff’s favor. Id. (quoting Boschetto v. Hansing, 539 F.3d 1011, 1015 (9th Cir. 2008)). “Additionally, any evidentiary materials submitted on the motion ‘are construed in the light most favorable to the plaintiff[s] and all doubts are resolved in [their] favor.’” Ochoa v. J.B. Martin & Sons Farms, 287 F.3d 1182, 1187 (9th Cir. 2002) (quoting Metro Life Ins. Co. v. Neaves, 912 F.2d 1062, 1064 n.1 (9th Cir. 1990)). “Declarations and affidavits are functional equivalents” in the context of a motion to dismiss. LNS Enters. LLC, 22 F.4th at 858. Defendants’ arguments are supported by two separate declarations by Jenifer Lynn Grace, the Corporate Secretary of Innov8tive, Manager of LCE, and the Corporate Secretary for the LaCore Entities. ECF Nos. 8-2, 10- 1. Pla

Free access — add to your briefcase to read the full text and ask questions with AI

Youngevity International Inc. v. Innov8tive Nutrition, Inc., (S.D. Cal. 2023).

Youngevity International Inc. v. Innov8tive Nutrition, Inc. (Youngevity International Inc. v. Innov8tive Nutrition, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Milliken v. Meyer
311 U.S. 457 (Supreme Court, 1941)
International Shoe Co. v. Washington
326 U.S. 310 (Supreme Court, 1945)
Foman v. Davis
371 U.S. 178 (Supreme Court, 1962)
Calder v. Jones
465 U.S. 783 (Supreme Court, 1984)
Burger King Corp. v. Rudzewicz
471 U.S. 462 (Supreme Court, 1985)
Getz v. Boeing Co.
654 F.3d 852 (Ninth Circuit, 2011)
United States v. James Martorano
557 F.2d 1 (First Circuit, 1977)
Sher v. Johnson
911 F.2d 1357 (Ninth Circuit, 1990)
Fiore v. Walden
657 F.3d 838 (Ninth Circuit, 2011)